FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18249011000001104: Adcirca 20mg tablets (Eli Lilly and Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62622801000001115 Adcirca 20mg tablets (Eli Lilly and Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62622901000001114 Adcirca 20mg tablets (Eli Lilly and Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Adcirca 20mg tablets (Eli Lilly and Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Adcirca 20mg tablets (Eli Lilly and Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Adcirca 20mg tablets (Eli Lilly and Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Adcirca 20mg tablets (Eli Lilly and Company Ltd) Is a Product containing precisely tadalafil 20 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Adcirca 20mg tablets (Eli Lilly and Company Ltd) Has active ingredient Tadalafil false Inferred relationship Existential restriction modifier
Adcirca 20mg tablets (Eli Lilly and Company Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Adcirca 20mg tablets (Eli Lilly and Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Adcirca 20mg tablets (Eli Lilly and Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Adcirca 20mg tablets (Eli Lilly and Company Ltd) Has specific active ingredient Tadalafil true Inferred relationship Existential restriction modifier
Adcirca 20mg tablets (Eli Lilly and Company Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Adcirca 20mg tablets (Eli Lilly and Company Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Adcirca 20mg tablets (Eli Lilly and Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Adcirca 20mg tablets (Eli Lilly and Company Ltd) Is a Adcirca true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Adcirca 20mg tablets (Eli Lilly and Company Ltd) 56 tablet 4 x 14 tablets Has AMP True Adcirca 20mg tablets (Eli Lilly and Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start